We discussed the long term Phase I results this Summer, these results may not be statistically significant, these results may only include 11 of the 22 people in the original trial and again may not be statistically significant. Next, Wilson entered into financing earlier this year that created up to two million additional warrrants at $~2.97/share for new investors that purchased new shares at $2.97 and the warrants have no restricitons. These warrants have been registered and what do you think the new investors are going to do when the share price pops over $3.00/share, look to sell right, These new investors are going to sell shares to cover initial investment, that is how it works. Additionally, there are also millions of other warrants some priced as low as $1.20/share that investors are just itching to sell. Finally, Wilson, TPIV management and BOD flat out lied in the last few years setting several milestones and deadlines that were never met and will be investigated and legal action coming, just a sham, people should go to jail.
Now Hoang announces that one patient has been enrolled on a trial that should have been fully underway over at least a year ago. What I want to know, have they any more patients enrolled or is this just window dressing, Hoang better be careful what he is reporting to the market. So we have a long way to go before you see your fantasy share prices. Also what is an "Acting" Chief Medical Officer, Kenney is either the man or not. GLTA, don't go out and spend your profits just yet. Finally, if everything is so great, whay have we not heard from AZN or have a paper published in a journal or structured a good financing deal. why, because this is still a "POS" stock without any real data or trial results.
News 
Market Data 
Discover 
